Arthritis & Rheumatism · 2009 · 121 citations · 35 references
EngineeringBioengineeringCell BiologyRegenerative MedicineStem Cell BiologyTissue EngineeringCartilage BiologyCartilage MetabolismCartilage RegenerationCartilage Tissue EngineeringMesenchymal DifferentiationMesenchymal Stem Cell TherapyChondrogenic DifferentiationOsteogenic MarkersStem Cell-based Cartilage EngineeringStem Cell-based Cartilage RegenerationStem Cell-seeded Constructs
OBJECTIVE: Osteoarthritis is characterized by an imbalance in cartilage homeostasis, which could potentially be corrected by mesenchymal stem cell (MSC)-based therapies. However, in vivo implantation of undifferentiated MSCs has led to unexpected results. This study was undertaken to establish a model for preconditioning of MSCs toward chondrogenesis as a more effective clinical tool for cartilage regeneration. METHODS: A coculture preconditioning system was used to improve the chondrogenic potential of human MSCs and to study the detailed stages of chondrogenesis of MSCs, using a human MSC line, Kp-hMSC, in commitment cocultures with a human chondrocyte line, hPi (labeled with green fluorescent protein [GFP]). In addition, committed MSCs were seeded into a collagen scaffold and analyzed for their neocartilage-forming ability. RESULTS: Coculture of hPi-GFP chondrocytes with Kp-hMSCs induced chondrogenesis, as indicated by the increased expression of chondrogenic genes and accumulation of chondrogenic matrix, but with no effect on osteogenic markers. The chondrogenic process of committed MSCs was initiated with highly activated chondrogenic adhesion molecules and stimulated cartilage developmental growth factors, including members of the transforming growth factor beta superfamily and their downstream regulators, the Smads, as well as endothelial growth factor, fibroblast growth factor, insulin-like growth factor, and vascular endothelial growth factor. Furthermore, committed Kp-hMSCs acquired neocartilage-forming potential within the collagen scaffold. CONCLUSION: These findings help define the molecular markers of chondrogenesis and more accurately delineate the stages of chondrogenesis during chondrocytic differentiation of human MSCs. The results indicate that human MSCs committed to the chondroprogenitor stage of chondrocytic differentiation undergo detailed chondrogenic changes. This model of in vitro chondrogenesis of human MSCs represents an advance in cell-based transplantation for future clinical use.
35
Multilineage Potential of Adult Human Mesenchymal Stem Cells
Mark F. Pittenger, Alastair M. Mackay, Stephen C. Beck et al. · Science · 1999 · 21.1K citations
Arnold I. Caplan · Journal of Orthopaedic Research® · 1991 · 6.5K citations
Mesenchymal Stem Cells in the Wharton's Jelly of the Human Umbilical Cord
Hwai‐Shi Wang, Shih‐Chieh Hung, Shu‐Tine Peng et al. · Stem Cells · 2004 · 1.4K citations · Full text
Mary B. Goldring, Kaneyuki Tsuchimochi, Kosei Ijiri · Journal of Cellular Biochemistry · 2005 · 1.1K citations · Full text